Position in NVS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$618,573
+$394 QoQ
Shares Held
3,947
-2.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#798
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Violich Capital Management, Inc. holds $62,484,887 across 7 Drug Manufacturers - General names. NVS ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
109,254 | $27,492,676 | |
| 2 | JNJ |
Johnson & Johnson
|
87,990 | $22,346,820 | |
| 3 | MRK |
Merck & Co., Inc.
|
50,257 | $6,458,024 | |
| 4 | AMGN |
Amgen Inc
|
9,350 | $3,385,822 | |
| 5 | LLY |
ELI LILLY & Co
|
1,291 | $1,548,464 | |
| 6 | PFE |
Pfizer Inc
|
26,350 | $634,508 | |
| 7 | NVS |
Novartis AG
This page
|
3,947 | $618,573 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $618,573 | 3,947 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $618,179 | 4,047 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $599,320 | 4,347 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $557,459 | 4,347 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $532,080 | 4,397 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $490,177 | 4,397 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $427,872 | 4,397 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $507,468 | 4,412 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $469,701 | 4,412 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $426,772 | 4,412 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $429,122 | 4,250 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $432,905 | 4,250 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $428,867 | 4,250 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $391,000 | 4,250 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $385,560 | 4,250 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $323,042 | 4,250 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $393,064 | 4,650 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $408,037 | 4,650 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $414,607 | 4,740 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $387,637 | 4,740 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $359,485 | 3,940 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $405,175 | 4,740 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $447,598 | 4,740 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $412,190 | 4,740 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $689,636 | 7,896 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $638,163 | 7,740 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||